Walmart Q2 FY2027: Revenue and EPS beat, US comps hit 6-yr low

The headline beat masks the more telling detail: Walmart's US comps slowed to a six-year low, and the culprit is pharmacy price deflation rather than weakening traffic. That distinction matters for anyone tracking consumer health, because it suggests the drag is category-specific, not a broad pullback — though the guidance range that still trails consensus implies management sees softer momentum ahead. Whether pharmacy deflation keeps distorting comps, or broader discretionary demand starts to soften too, is the open question.